Preclinical, Pharmacological and Toxicological studies of Karpoora Chindhamani Mathirai (KCM) for Analgesic, Anti-inflammatory, Anti-pyretic effects in rats
DOI:
https://doi.org/10.47552/ijam.v3i1.111Keywords:
Karpoora Chindhamani Mathirai, Rheumatoid arthritis, anti-inflammatory, antipyretic, analgesicAbstract
Siddha system of medicine is indigenous to India. The drug Karpoora Chindhamani Mathirai chosen from classic Siddha text is subjected to preclinical toxicity studies and for analgesic, anti-inflammatory and antipyretic effects in rats. These preclinical studies are performed to bring a strong evidence based support on the traditional medicine. Toxicity studies are performed as per OECD guidelines and Karpoora Chindhamani Mathirai at the dose of 2000 mg/kg/po did not exhibit any mortality in rats. Karpoora Chindhamani Mathirai exhibited significant anti inflammatory activity in both carrageenin induced hind paw and cotton pellet granuloma model in rats. The results are comparable to Diclofenac sodium (5gm/ kg/po). Karpoora Chindhamani Mathirai also exhibited significant antipyretic and analgesic activity.
Published
How to Cite
Issue
Section
License
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.
